» Read discussion on Nature Biotechnology 03/21/11 Scientists have developed a new way of administering drugs to the brain to treat Alzheimer's disease, according to a study published last Sunday in 'Nature Biotechnology'. Researchers at Oxford University injected exosomes - tiny particles naturally released by cells - into the blood of mice. They found that for the first time, using this 'natural' system they were able to transfer potential new ...
12/06/10 Bioengineers from the University of California, San Diego developed an explanation for why some types of neurons die sooner than others in the brains of people with Alzheimer's disease. These insights, published in the journal Nature Biotechnology on November 21, come from detailed models of brain energy metabolism developed in the Department of Bioengineering at the UC San Diego Jacobs School ...
08/24/10 A research team co-led by scientists from the J. Craig Venter Institute (JCVI) and the Institute for Genome Sciences (IGS), University of Maryland School of Medicine, published the sequence and analysis of the castor bean (Ricinus communis) genome in Nature Biotechnology. Agnes P. Chan, Ph.D., JCVI, and Jonathan Crabtree, Ph.D., IGS were co-lead authors on the paper describing the 4.5X coverage ...
08/22/10 ROCKVILLE, Md., Aug. 22 /PRNewswire-USNewswire/ -- A research team co-led by scientists from the J. Craig Venter Institute (JCVI) and the Institute for Genome Sciences (IGS), University of Maryland School of Medicine, today published the sequence and analysis of the castor bean (Ricinus communis) genome in Nature Biotechnology. Agnes P. Chan, Ph.D., JCVI, and Jonathan Crabtree, Ph.D., IGS were ...
05/12/10 The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech firms in developing countries, according to a study to be published Mon. May 10 in the UK journal Nature Biotechnology...
03/30/10 Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have ...
01/19/10 CAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia .
12/27/09 ( MacDougall Biomedical Communications, Inc. ) Emerald BioStructures announced today a publication in the Dec. 27, 2009, advance online issue of Nature Biotechnology, detailing the application of structure-based drug design to engineer new allosteric small molecule modulators of the enzyme phosphodiesterase-4 (PDE4), with reduced side effects. According to the paper, the researchers established ...
11/15/09 REDWOOD CITY, CA and MOUNTAIN VIEW, CA--(Marketwire - 11/15/09) - Amunix, Inc. and Versartis, Inc. announced today that the scientific journal Nature Biotechnology has published a comprehensive paper entitled "A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner." The paper ( http://dx.doi.org/10.1038/nbt.1588 ) describes ...
11/15/09 REDWOOD CITY, CA and MOUNTAIN VIEW, CA--(Marketwire - November 15, 2009) - Amunix, Inc. and Versartis, Inc. announced today that the scientific journal Nature Biotechnology has published a comprehensive paper entitled "A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner." The paper ( http://dx.doi.org/10.1038/nbt.1588 ...
08/17/09 A study published in the online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers. Chemical modification of DNA via the addition or deletion of methyl groups has been established as a common biological means of activating or silencing genes.
08/16/09 A study published in this week's online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers.Chemical modification of DNA via the addition or deletion of methyl groups has been established as a common biological means of activating or silencing genes.
08/16/09 A study published in this week's online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers. | 
